Stoke Therapeutics Inc buy Canaccord Genuity Group Inc.
Start price
04.08.26
/
50%
€25.52
Target price
04.08.27
€50.39
Performance (%)
6.23%
Price
06.08.26
€27.11
Summary
This prediction is currently active. The BUY prediction by Canaccord_Genuity_Gr shows slight gains of 6.23%. This prediction currently runs until 04.08.27. The prediction end date can be changed by Canaccord_Genuity_Gr at any time. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Stoke Therapeutics Inc | 6.23% |
| iShares Core DAX® | 1.842% |
| iShares Nasdaq 100 | 4.659% |
| iShares Nikkei 225® | 3.963% |
| iShares S&P 500 | 3.700% |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics (STOK) had its price target lowered by Canaccord Genuity Group Inc. from $60.00 to $58.00. They now have a "buy" rating on the stock.
Ratings data for STOK provided by MarketBeat
Stopped prediction by Canaccord_Genuity_Gr for Stoke Therapeutics Inc
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€28.40
20.03.26
20.03.26
€51.88
20.03.27
20.03.27
-4.08%
06.08.26
06.08.26
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€8.85
28.04.23
28.04.23
€21.78
28.04.24
28.04.24
28.81%
29.04.24
29.04.24